The chief clinical officer of health plans and policy for Quest Diagnostics discusses how payers can assess the value of genetic testing in oncology.
L. Patrick James, MD
Advertisement
Articles by L. Patrick James, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
3
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
4
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
5